Cite

HARVARD Citation

    Lee, J. et al. (2011). Clinical and health economic outcomes of alternative HER2 test strategies for guiding adjuvant trastuzumab therapy. Expert review of pharmacoeconomics & outcomes research. pp. 325-341. [Online]. 
  
Back to record